CLASS II ONGOING Drug recall · Reported 24 Dec 2025 · FDA Enforcement Report

Ciclopirox Shampoo recalled by Sun Pharma /taro

Sun Pharma /taro is recalling Ciclopirox Shampoo, 1%, distributed nationwide in the US. The recall was initiated on 9 Dec 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: AD37059, AD37060, AD37061, AD37062, AD37065, AD37066, AD37067, AD37068, expires: 1/31/2026.
Quantity recalled17,664 units

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0240-2026
FDA event ID
98104
Recalling firm
Sun Pharma /taro, Hawthorne, NY
Classification
Class II
Status
Ongoing
Recall initiated
9 Dec 2025
FDA classified
17 Dec 2025
Reported
24 Dec 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

9 Dec 2025Recall initiated by company
17 Dec 2025Classified by FDA+8 days
24 Dec 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Ciclopirox Shampoo, 1%, 120 mL, Rx only, Mfg by: Taro Pharmaceuticals Inc., Ontario, Canada; Dist. by: Taro Pharmaceuticals USA, Inc., NY 10532. NDC 51672-1351-08

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Is Ciclopirox Shampoo, 1% recalled?

Yes. Sun Pharma /taro recalled Ciclopirox Shampoo, 1% on 9 Dec 2025. The recall is Class II and its status is Ongoing. Recall number D-0240-2026.

Why was it recalled?

Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint

Which lots are affected?

Lot #: AD37059, AD37060, AD37061, AD37062, AD37065, AD37066, AD37067, AD37068, expires: 1/31/2026.

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.